Next Article in Journal
Topoisomerase II Inhibitors Can Enhance Baculovirus-Mediated Gene Expression in Mammalian Cells through the DNA Damage Response
Next Article in Special Issue
Toxicological Effects of Caco-2 Cells Following Short-Term and Long-Term Exposure to Ag Nanoparticles
Previous Article in Journal
Potential Benefits of Dietary Fibre Intervention in Inflammatory Bowel Disease
Previous Article in Special Issue
Inhaled Cadmium Oxide Nanoparticles: Their in Vivo Fate and Effect on Target Organs
Article Menu
Issue 6 (June) cover image

Export Article

Open AccessReview
Int. J. Mol. Sci. 2016, 17(6), 929; doi:10.3390/ijms17060929

Toxicological Considerations, Toxicity Assessment, and Risk Management of Inhaled Nanoparticles

1
School of Health & Society, The University of Wollongong, Wollongong NSW 2522, Australia
2
School of Chemistry, The University of New South Wales, Sydney NSW 2052, Australia
*
Author to whom correspondence should be addressed.
Academic Editors: Michael Routledge and Bing Yan
Received: 16 March 2016 / Revised: 25 May 2016 / Accepted: 25 May 2016 / Published: 14 June 2016
(This article belongs to the Special Issue Cellular Toxicity of Nanoparticles)
View Full-Text   |   Download PDF [941 KB, uploaded 14 June 2016]   |  

Abstract

Novel engineered nanoparticles (NPs), nanomaterial (NM) products and composites, are continually emerging worldwide. Many potential benefits are expected from their commercial applications; however, these benefits should always be balanced against risks. Potential toxic effects of NM exposure have been highlighted, but, as there is a lack of understanding about potential interactions of nanomaterials (NMs) with biological systems, these side effects are often ignored. NPs are able to translocate to the bloodstream, cross body membrane barriers effectively, and affect organs and tissues at cellular and molecular levels. NPs may pass the blood–brain barrier (BBB) and gain access to the brain. The interactions of NPs with biological milieu and resulted toxic effects are significantly associated with their small size distribution, large surface area to mass ratio (SA/MR), and surface characteristics. NMs are able to cross tissue and cell membranes, enter into cellular compartments, and cause cellular injury as well as toxicity. The extremely large SA/MR of NPs is also available to undergo reactions. An increased surface area of the identical chemical will increase surface reactivity, adsorption properties, and potential toxicity. This review explores biological pathways of NPs, their toxic potential, and underlying mechanisms responsible for such toxic effects. The necessity of toxicological risk assessment to human health should be emphasised as an integral part of NM design and manufacture. View Full-Text
Keywords: inhalation; nanoparticles; nanomaterials; physicochemical properties; toxicity mechanism; risk assessment inhalation; nanoparticles; nanomaterials; physicochemical properties; toxicity mechanism; risk assessment
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Bakand, S.; Hayes, A. Toxicological Considerations, Toxicity Assessment, and Risk Management of Inhaled Nanoparticles. Int. J. Mol. Sci. 2016, 17, 929.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top